newsfilter
← Latest News
Business Wire·

AlloVir to Present at the BofA Securities 2023 Health Care Conference

AlloVir, Inc. (NASDAQ:ALVR), a late-clinical stage allogeneic T cell immunotherapy company, announced today that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the BofA Securities